Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000696995 | SCV000825582 | benign | Tuberous sclerosis 2 | 2023-07-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001017661 | SCV001178779 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-04-04 | criteria provided, single submitter | clinical testing | The p.H985R variant (also known as c.2954A>G), located in coding exon 25 of the TSC2 gene, results from an A to G substitution at nucleotide position 2954. The histidine at codon 985 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000696995 | SCV002040737 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003320729 | SCV004025428 | uncertain significance | not provided | 2024-05-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |